Teva Pharmaceutical Industries Ltd
TEVA
NYSE
Pharmaceuticals
$34.71
USD
+3.04 (+9.60%)
At close: Jul 29, 2026, 4:00 PM EDT
Market Cap $36.24B
Volume 17.8M
About Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. The company employs 31,173 full-time employees The firm operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
CEO
Mr. Richard Francis
HQ
TEL AVIV-YAFO, IL
Founded
1951
Employees
31,173
Quantli Score
8.4
Outperform
Fin. Health
8.1
Profitability
7.6
Growth
9.0
Cash-Flow Q.
8.8
Key Metrics
6 metrics our research team weighs before forming a view on TEVA.
Based on Quantli research · SEC filings · as of Q1 2026
METRIC
VALUE
CHANGE
TREND (3Y)
Revenue Growth (TTM)
4.4%
+0.6 pp
Gross Margin (TTM)
52.1%
+2.9 pp
Operating Margin (TTM)
13.2%
+10.6 pp
Net Margin (TTM)
9.0%
+17.0 pp
ROE (TTM)
19.0%
+40.1 pp
Free Cash Flow (TTM)
$1.17B
+53.0%
Financial Snapshot
Revenue
$17.35B
+4.4%
YoY
Gross Margin
52%
TTM
+5.9%
YoY
Net Income
$1.57B
+218.8%
YoY
Operating Cash Flow
$1.71B
+35.3%
YoY
Key Statistics
Open
$33.67
Previous Close
$31.67
Day Range
$33.48 - $35.69
52 Week Range
$14.99 - $37.35
Volume
17.8M
Average Volume (10 Days)
860.0K
Market Cap
$36.24B
P/E Ratio (TTM)
23.25
P/S Ratio (TTM)
2.09
Dividend Yield
—
Valuation Measurement
Market Cap
$36.24B
Trailing P/E
23.25
Price / Sales
2.09
Price / Book
4.40
Financial Highlights
Profit Margin
9.0%
Return on Assets
3.9%
Return on Equity
19.0%
Revenue (TTM)
$17.35B
Net Income (TTM)
$1.57B
Diluted EPS (TTM)
$1.33
Total Cash (MRQ)
$3.74B
Levered FCF (TTM)
$1.17B
Latest News
Load more
Turn research into action
Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.
Analyst Consensus
Based on 1 analyst ratings
Avg Target: $40.00
(+15.2% upside)
High: $40.00 · Low: $40.00
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%